AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
New J&J plant may create 1,000 jobs.
(From Irish Independent)
JOHNSON & Johnson, the global healthcare giant, is considering a further investment in Ireland that could create up to 1,000 new jobs.
Senior executives from one of its subsidiaries have visited a number of sites in the Munster area, and Tipperary in particular, in its search for a new investment location.
The executives are looking for a well-serviced site capable of holding a 200,000 sq ft facility, indicating an investment of at least 100m.
The multinational has indicated that if it invests it would create 300 jobs within three years and could eventually take on up to 1,000 people.
The J&J subsidiary eyeing up Ireland is believed to be Cordis, which makes heart stents, among other products. A spokeswoman ...
- Attack of the warrior fungus.(Janssen Pharmaceutical NV hired to combat fungu...
- Magazine article from: Geographical DA December 1, 2000 700+ words
...ancient guardians. Belgian's Janssen Pharmaceutical NV, which specialises in...anti-fungal experts." Janssen Pharmaceutical NV is working with the museum and Xi'an Janssen Pharmaceutical Ltd., one of the largest...
- Aciphex approval.(antiulcer drug from Eisai Inc. and Janssen...
- Magazine article from: Chain Drug Review September 27, 1999 700+ words
The FDA has approved a new treatment for reflux disease and duodenal ulcers. Eisai Inc. and Janssen Pharmaceutical will comarket the drug under the Aciphex brand name.
- J&J Files NDA for New Formulation for Risperdal.(Johnson and Johnson's Janssen...
- Magazine article from: Chemical Market Reporter Krause, Carey September 10, 2001 700+ words
HOLDING ITS LEAD in the schizophrenia market, Johnson & Johnson's Janssen Pharmaceutical Products LP has filed a new drug application with the Food & Drug Administration for a long-acting injectable formulation...
- ITRACONAZOLE.(Janssen Pharmaceutical receives approval for Sporanex)
- Magazine article from: Chemical Market Reporter April 12, 1999 700+ words
Janssen Pharmaceutica, Beerse, Belgium, a wholly owned subsidiary of Johnson & Johnson, has received FDA approval for Sporanex (itraconazole) Injection, a new intravenous treatment for several fungal infections that are potentially life-threatening.
- Hot water system. (Product News).(Janssen Pharmaceutical Ltd. receives hot...
- Magazine article from: Chemistry and Industry February 17, 2003 700+ words
Janssen Pharmaceuticals is more than doubling capacity at part of its plant in Little Island, County Cork, with help from a skid-mounted hot water system from Spirax Sarco. The demand for hot water to heat five jacketed batch reactors varies considerably. The earlier system fed hot water from a
- OSI SOFTWARE INC.(implements PI System at Janssen Pharmaceutical Ltd.)(Brief...
- Magazine article from: Chemical Market Reporter October 25, 1999 700+ words
OSI SOFTWARE INC. reports that Jansseen Pharmaceutical Ltd. has implemented OSI's PI System as part of the phased implementation of its SAP R/3 business system.
- R.P. Scherer announces agreement. (with Janssen Pharmaceutical N.V.)
- Press release article from: PR Newswire August 21, 1990 700+ words
R.P. SCHERER ANNOUNCES AGREEMENT TROY, Mich., Aug. 21 /PRNewswire/ -- R.P. Scherer Corporation announced today that it has entered into a second agreement with Janssen Pharmaceutica N.V. for the development of another of Janssen's pharmaceutical products utilizing Scherer's ZYDIS(R) fast dissolving
- Janssen: 'Dear Doctor' letter for risperidone.(increased stroke risk)(Janssen...
- Newspaper article from: Sports Medicine Reports Elliott, William T. June 1, 2003 700+ words
Janssen pharmaceuticals has issued a "Dear Doctor" letter concerning its antipsychotic medication risperidone (Risperdal[R The letter warns health-care providers about a possible increased risk of stroke among elderly patients taking the drug. "Cerebrovascular adverse events (eg, stroke, transient
